尔康制药 (300267.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−33.9x

Market Cap

CNY 6.54B

MomentumView details →

1D Return

−1.55%

YTD Return

−5.28%

RSI (14)

47.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−33.9x

Market Cap

CNY 6.54B

RSI (14)

47.7

MomentumView details →

1D Return

−1.55%

YTD Return

−5.28%

ProfitabilityView details →

Gross Margin

27.01%

Net Margin

−37.26%

EBITDA Margin

−17.66%

ROE (TTM)

−9.82%

ROA (TTM)

−7.96%

Asset Turnover

0.22x

GrowthView details →

Revenue YoY

−12.96%

EPS YoY

−13.40%

FCF YoY

+481.07%

Revenue CAGR 3Y

−14.58%

EPS CAGR 3Y

−1.71%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.18x

Current Ratio

2.09x

Quick Ratio

1.52x

Div Yield

—

Div Rate

—

Div Growth 1Y

−40.00%

Financials snapshotView financials →

Revenue (TTM)

1.06B

Net Income (TTM)

−394.82M

Op. CF (TTM)

251.92M

Latest newsMore news →

Erkang Pharmaceutical's controlling shareholder Shuai Fangwen completed a share reduction plan, selling 10.776 million shares via centralized bidding at an average price of 4.38 yuan per share.45d ago

Similar companies

天铁科技300587.SZ 双鹭药业002038.SZ 万顺新材300057.SZ 华统股份002840.SZ 新联电子002546.SZ 珠江钢琴002678.SZ Find similar companies →

Latest newsMore news →

Erkang Pharmaceutical's controlling shareholder Shuai Fangwen completed a share reduction plan, selling 10.776 million shares via centralized bidding at an average price of 4.38 yuan per share.45d ago